These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32148245)

  • 1. [Study progress of role of co-suppressor molecules in sepsis immune dysfunction].
    Gao J; Liu Z; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):121-125. PubMed ID: 32148245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting Edge: 2B4-Mediated Coinhibition of CD4
    Chen CW; Mittal R; Klingensmith NJ; Burd EM; Terhorst C; Martin GS; Coopersmith CM; Ford ML
    J Immunol; 2017 Sep; 199(6):1961-1966. PubMed ID: 28768726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Immune Cell Checkpoints during Sepsis.
    Patil NK; Guo Y; Luan L; Sherwood ER
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis erodes CD8
    Xie J; Crepeau RL; Chen CW; Zhang W; Otani S; Coopersmith CM; Ford ML
    J Leukoc Biol; 2019 Mar; 105(3):565-575. PubMed ID: 30624806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
    Kim N; Kim HS
    Front Immunol; 2018; 9():2041. PubMed ID: 30250471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of T cell immunoglobulin mucin molecule 1 in the pathogenesis of sepsis].
    Kang S; Buzukela A; Li Y; Baihetinisha T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):364-367. PubMed ID: 33834983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction.
    Cao C; Chai Y; Shou S; Wang J; Huang Y; Ma T
    Int Immunopharmacol; 2018 Jan; 54():169-176. PubMed ID: 29149705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
    Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.
    Cheng T; Bai J; Chung CS; Chen Y; Biron BM; Ayala A
    Shock; 2016 Jan; 45(1):40-9. PubMed ID: 26674453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CD94/NKG2 in innate and adaptive immunity.
    Gunturi A; Berg RE; Forman J
    Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality.
    Lange A; Sundén-Cullberg J; Magnuson A; Hultgren O
    PLoS One; 2017; 12(1):e0169176. PubMed ID: 28056053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors for cancer treatment.
    Park J; Kwon M; Shin EC
    Arch Pharm Res; 2016 Nov; 39(11):1577-1587. PubMed ID: 27770382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).
    Watzl C; Stebbins CC; Long EO
    J Immunol; 2000 Oct; 165(7):3545-8. PubMed ID: 11034353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell Co-inhibitory Molecules in Sepsis-induced Immunosuppression: From Bench to Bedside.
    Xie JF; Qiu HB; Yang Y
    Chin Med J (Engl); 2017 May; 130(10):1249-1252. PubMed ID: 28485327
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cellular events in the pathophysiology of sepsis.
    Bhan C; Dipankar P; Chakraborty P; Sarangi PP
    Inflamm Res; 2016 Nov; 65(11):853-868. PubMed ID: 27392441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.